Literature DB >> 6131061

Stimulant drug effects in developmental disorders and hyperactivity--toward a resolution of disparate findings.

M G Aman.   

Abstract

An attempt is made to integrate data from a variety of clinical populations and from the animal literature. Evidence is presented suggesting that mentally retarded and autistic children generally show a poor response to stimulant medication, whereas hyperactive and normal children respond beneficially. Cognitive research in mentally retarded and autistic children is reviewed, and it is suggested that both diagnostic groups suffer from attentional difficulties, the mechanisms of which may be very similar. The literature on stimulant-induced stereotypy in animals is discussed, with emphasis on the clinical implications for autism and mental retardation. An attentional model is proposed to account for type of therapeutic response to stimulant medication. This is followed by a possible method for testing the model and by specific predictions relating to subject characteristics and response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6131061     DOI: 10.1007/bf01538326

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  55 in total

1.  Possible mechanisms involved in the stereotyped behavior elicited by amphetamine.

Authors:  P M Groves
Journal:  Biol Psychiatry       Date:  1977-06       Impact factor: 13.382

2.  Stimulus overselectivity: a common feature in autism and mental retardation.

Authors:  H Wilhelm; O I Lovaas
Journal:  Am J Ment Defic       Date:  1976-07

3.  DOPA and other naturally occurring substances as causes of stereotypy and rage in rats.

Authors:  A Randrup; I Munkvad
Journal:  Acta Psychiatr Scand Suppl       Date:  1966

4.  Selective responding by autistic children to multiple sensory input.

Authors:  O I Lovaas; L Schreibman; R Koegel; R Rehm
Journal:  J Abnorm Psychol       Date:  1971-06

5.  Levodopa and levoamphetamine: a crossover study in young schizophrenic children.

Authors:  M Campbell; A M Small; P J Collins; E Friedman; R David; N Genieser
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

Review 6.  Pharmacology and physiology of stereotyped behavior.

Authors:  A Randrup; I Munkvad
Journal:  J Psychiatr Res       Date:  1974       Impact factor: 4.791

7.  The effect of appealing distractors on the performance of hyperactive children.

Authors:  A Radosh; R Gittelman
Journal:  J Abnorm Child Psychol       Date:  1981-06

8.  Psychotropic drugs and learning problems--a selective review.

Authors:  M G Aman
Journal:  J Learn Disabil       Date:  1980-02

9.  The effects of methylphenidate (Ritalin) on the motor skills and behavior of children with learning problems.

Authors:  R M Knights; G G Hinton
Journal:  J Nerv Ment Dis       Date:  1969-06       Impact factor: 2.254

10.  The effectiveness of methylphenidate hydrochloride (ritalin) on learning and behavior in public school educable mentally retarded children.

Authors:  V Y Blacklidge; R L Ekblad
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

View more
  10 in total

1.  Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

Authors:  Thomas W Frazier; Paul T Shattuck; Sarah Carter Narendorf; Benjamin P Cooper; Mary Wagner; Edward L Spitznagel
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-12-13       Impact factor: 2.576

Review 2.  Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.

Authors:  M G Aman; K S Langworthy
Journal:  J Autism Dev Disord       Date:  2000-10

3.  Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

Authors:  J Kitanaka; N Kitanaka; T Tatsuta; F S Hall; G R Uhl; K Tanaka; N Nishiyama; Y Morita; M Takemura
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

4.  Guanfacine extended release in two patients with pervasive developmental disorders.

Authors:  Kelly Blankenship; Craig A Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

5.  Separate and combined effects of methylphenidate and a behavioral intervention on disruptive behavior in children with mental retardation.

Authors:  N J Blum; J E Mauk; J J McComas; F C Mace
Journal:  J Appl Behav Anal       Date:  1996

6.  Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: laboratory effects.

Authors:  M G Aman; R A Kern; D E McGhee; L E Arnold
Journal:  J Autism Dev Disord       Date:  1993-09

7.  Hyperactivity: nature of the syndrome and its natural history.

Authors:  M G Aman
Journal:  J Autism Dev Disord       Date:  1984-03

8.  Hyperactivity and the fragile X syndrome.

Authors:  S Einfeld; W Hall; F Levy
Journal:  J Abnorm Child Psychol       Date:  1991-06

9.  Prediction of clinical response in children taking methylphenidate.

Authors:  M G Aman; S H Turbott
Journal:  J Autism Dev Disord       Date:  1991-06

10.  Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Authors:  Deborah A Pearson; Cynthia W Santos; Michael G Aman; L Eugene Arnold; Charles D Casat; Rosleen Mansour; David M Lane; Katherine A Loveland; Oscar G Bukstein; Susan W Jerger; Perry Factor; Salome Vanwoerden; Evelyn Perez; Lynne A Cleveland
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.